$KOSS
KOSS CORP

2020 Q2 Form 10-K Financial Statement

#000005670121000024 Filed on August 20, 2021

View on sec.gov

Income Statement

Concept 2020 Q2 2020 2019 Q2
Revenue $3.950M $18.31M $5.790M
YoY Change -31.78% -16.16% -20.03%
Cost Of Revenue $2.590M $12.65M $4.110M
YoY Change -36.98% -15.8% -20.66%
Gross Profit $1.360M $5.663M $1.670M
YoY Change -18.56% -16.97% -18.93%
Gross Profit Margin 34.43% 30.92% 28.84%
Selling, General & Admin $1.210M $6.147M $1.650M
YoY Change -26.67% -6.07% -4.07%
% of Gross Profit 88.97% 108.55% 98.8%
Research & Development $397.4K
YoY Change
% of Gross Profit 7.02%
Depreciation & Amortization $70.00K $330.6K $90.00K
YoY Change -22.22% -23.06% -35.71%
% of Gross Profit 5.15% 5.84% 5.39%
Operating Expenses $1.210M $6.544M $1.660M
YoY Change -27.11% 0.01% -3.49%
Operating Profit $150.0K -$484.0K $10.00K
YoY Change 1400.0% -275.18% -97.06%
Interest Expense $0.00 $20.19K $0.00
YoY Change 535.15%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net
YoY Change
Pretax Income $150.0K -$463.9K $20.00K
YoY Change 650.0% -265.97% -94.12%
Income Tax $0.00 $1.740K $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $160.0K -$465.6K $20.00K
YoY Change 700.0% -252.16% -94.29%
Net Earnings / Revenue 4.05% -2.54% 0.35%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share $21.62K -$0.06 $2.699K
COMMON SHARES
Basic Shares Outstanding 7.405M 7.405M 7.405M shares
Diluted Shares Outstanding 7.405M

Balance Sheet

Concept 2020 Q2 2020 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.000M $4.000M $2.230M
YoY Change 79.37% 79.37% 106.48%
Cash & Equivalents $3.999M $4.000M $2.228M
Short-Term Investments
Other Short-Term Assets $270.0K $270.0K $130.0K
YoY Change 107.69% 107.69% -38.1%
Inventory $5.539M $5.540M $6.851M
Prepaid Expenses
Receivables $2.317M $2.320M $3.655M
Other Receivables $10.00K $10.00K $40.00K
Total Short-Term Assets $12.14M $12.14M $12.91M
YoY Change -6.02% -5.96% 6.12%
LONG-TERM ASSETS
Property, Plant & Equipment $983.6K $3.570M $890.1K
YoY Change 10.51% -4.55% -21.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.459M $6.880M $9.431M
YoY Change 0.3% 4.56% -0.48%
Total Long-Term Assets $10.44M $10.44M $10.32M
YoY Change 1.18% 1.06% -2.71%
TOTAL ASSETS
Total Short-Term Assets $12.14M $12.14M $12.91M
Total Long-Term Assets $10.44M $10.44M $10.32M
Total Assets $22.58M $22.58M $23.24M
YoY Change -2.82% -2.84% 2.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $827.7K $830.0K $1.436M
YoY Change -42.38% -42.36% 0.48%
Accrued Expenses $580.1K $860.0K $650.5K
YoY Change -10.82% -6.52% -17.55%
Deferred Revenue $423.6K $645.5K
YoY Change -34.37% -6.58%
Short-Term Debt $506.7K $510.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.615M $2.620M $2.998M
YoY Change -12.77% -12.67% -5.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.810M $4.810M $5.170M
YoY Change -6.96% -6.96%
Total Long-Term Liabilities $4.809M $4.810M $5.165M
YoY Change -6.9% -6.96% -4.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.615M $2.620M $2.998M
Total Long-Term Liabilities $4.809M $4.810M $5.165M
Total Liabilities $7.424M $7.420M $8.163M
YoY Change -9.05% -9.07% -4.79%
SHAREHOLDERS EQUITY
Retained Earnings $8.236M $8.702M
YoY Change -5.35% 3.42%
Common Stock $6.920M $6.370M
YoY Change 8.63% 10.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.16M $15.16M $15.07M
YoY Change
Total Liabilities & Shareholders Equity $22.58M $22.58M $23.24M
YoY Change -2.82% -2.84% 2.01%

Cashflow Statement

Concept 2020 Q2 2020 2019 Q2
OPERATING ACTIVITIES
Net Income $160.0K -$465.6K $20.00K
YoY Change 700.0% -252.16% -94.29%
Depreciation, Depletion And Amortization $70.00K $330.6K $90.00K
YoY Change -22.22% -23.06% -35.71%
Cash From Operating Activities $1.460M $1.802M -$430.0K
YoY Change -439.53% 27.68% -12.24%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K $424.2K -$70.00K
YoY Change -57.14% 125.91%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$110.0K $0.00
YoY Change -8.33%
Cash From Investing Activities -$40.00K -$537.3K -$70.00K
YoY Change -42.86% 72.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 510.0K 506.7K 0.000
YoY Change 985.55%
NET CHANGE
Cash From Operating Activities 1.460M 1.802M -430.0K
Cash From Investing Activities -40.00K -537.3K -70.00K
Cash From Financing Activities 510.0K 506.7K 0.000
Net Change In Cash 1.930M 1.771M -500.0K
YoY Change -486.0% 54.45% 2.04%
FREE CASH FLOW
Cash From Operating Activities $1.460M $1.802M -$430.0K
Capital Expenditures -$30.00K $424.2K -$70.00K
Free Cash Flow $1.490M $1.378M -$360.0K
YoY Change -513.89% 12.61% -26.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000056701
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
0-3295
CY2021 dei Entity Registrant Name
EntityRegistrantName
KOSS CORPORATION
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-1168275
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
4129 North Port Washington Avenue
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Milwaukee
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53212
CY2021 dei City Area Code
CityAreaCode
414
CY2021 dei Local Phone Number
LocalPhoneNumber
964-5000
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.005 par value per share
CY2021 dei Trading Symbol
TradingSymbol
KOSS
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
15072897
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8673706
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6950215
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3999409
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
41500
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74082
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2240785
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2317064
CY2021Q2 us-gaap Inventory Net
InventoryNet
5901512
CY2020Q2 us-gaap Inventory Net
InventoryNet
5538794
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
456004
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
267647
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
14622
CY2021Q2 us-gaap Assets Current
AssetsCurrent
15548516
CY2020Q2 us-gaap Assets Current
AssetsCurrent
12137536
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1281180
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2052124
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2615090
CY2021Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2491482
CY2020Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2333482
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
983641
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2305455
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2582402
CY2021Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
7188994
CY2020Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
6876827
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9494449
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9459229
CY2021Q2 us-gaap Assets
Assets
26324145
CY2020Q2 us-gaap Assets
Assets
22580406
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
398433
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
827705
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
665567
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
580099
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
694632
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
423639
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
288949
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
276947
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
4543
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
506700
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
188932
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
170281
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2016506
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2305455
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4696920
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4809218
CY2021Q2 us-gaap Liabilities
Liabilities
6749044
CY2020Q2 us-gaap Liabilities
Liabilities
7424308
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8608706
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8608706
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7404831
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7404831
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
43044
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
37024
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
10802118
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6882729
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8729939
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8236345
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
497719
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-463857
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4125
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1740
CY2021 us-gaap Net Income Loss
NetIncomeLoss
493594
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
19575101
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
15156098
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26324145
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22580406
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19546008
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18311830
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12813873
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12649222
CY2021 us-gaap Gross Profit
GrossProfit
6732135
CY2020 us-gaap Gross Profit
GrossProfit
5662608
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7122627
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6146650
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-390492
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-484042
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
885505
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2706
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
20185
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-465597
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7864688
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7404831
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9639273
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7404831
CY2021 us-gaap Net Income Loss
NetIncomeLoss
493594
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-465597
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-9226
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
56386
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
302616
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
330629
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
619137
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
549594
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13276
CY2021 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
208116
CY2020 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
194083
CY2021 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
308000
CY2020 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
63520
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
289644
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-214568
CY2021 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
150000
CY2020 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
150000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
348740
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1801702
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
600155
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
424159
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
104051
CY2020 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
113116
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
19575101
CY2021 us-gaap Other Noncash Income
OtherNoncashIncome
506700
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-85505
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1281693
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
362718
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1312654
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
188357
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
133758
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-14622
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-31038
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4543
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-429272
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-608668
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
85468
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-70414
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-704206
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-537275
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
506700
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3306272
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3306272
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
506700
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2950806
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1771127
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3999409
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2228282
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6950215
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3999409
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
15072101
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-465597
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
549594
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
15156098
CY2021 us-gaap Net Income Loss
NetIncomeLoss
493594
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
619137
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3306272
CY2021Q2 koss Number Of Subsidiaries
NumberOfSubsidiaries
2
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.30
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.20
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
410602
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
397360
CY2021 us-gaap Advertising Expense
AdvertisingExpense
33976
CY2020 us-gaap Advertising Expense
AdvertisingExpense
54592
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">USE OF ESTIMATES — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.</span>
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19546008
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18311830
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
325962
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
427193
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
808488
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2067572
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1953031
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5621228
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5149200
CY2021Q2 us-gaap Inventory Gross
InventoryGross
7688800
CY2020Q2 us-gaap Inventory Gross
InventoryGross
7102231
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1787288
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1563437
CY2021Q2 us-gaap Inventory Net
InventoryNet
5901512
CY2020Q2 us-gaap Inventory Net
InventoryNet
5538794
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9530327
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8930172
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8249147
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7946531
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1281180
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
983641
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3259
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2765
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7741570
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
61948
CY2021 koss Effective Income Tax Rate Reconciliation Deduction Addback Employee Stock Ownership Plan Dividend Amount
EffectiveIncomeTaxRateReconciliationDeductionAddbackEmployeeStockOwnershipPlanDividendAmount
8326662
CY2020 koss Effective Income Tax Rate Reconciliation Deduction Addback Employee Stock Ownership Plan Dividend Amount
EffectiveIncomeTaxRateReconciliationDeductionAddbackEmployeeStockOwnershipPlanDividendAmount
-86541
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
543940
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
657464
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-15037
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4125
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3501
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
13276
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4125
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1740
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
104522
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-97409
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-172863
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-50610
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
30000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
22568
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-3303
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-30040
CY2021 koss Effective Income Tax Rate Reconciliation Adjustment To Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationAdjustmentToDeferredTaxAssetsAmount
40572
CY2020 koss Effective Income Tax Rate Reconciliation Adjustment To Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationAdjustmentToDeferredTaxAssetsAmount
44790
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-30887
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
18962
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
20453
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12639
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4125
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1740
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
664705
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
614018
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
116582
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
249313
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
479112
CY2021Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
222341
CY2020Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
146841
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8333391
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
606730
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
252192
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
216484
CY2021Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
57639
CY2020Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
134045
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
580053
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
638472
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10185605
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2444035
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
585238
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
640980
CY2021Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
580053
CY2020Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
638472
CY2021Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
5185
CY2020Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2508
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2444035
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7741570
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10185605
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2382087
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
61948
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2444035
CY2020Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
16363
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2021Q2 koss Cooperative Advertising And Promotion Allowances
CooperativeAdvertisingAndPromotionAllowances
201006
CY2020Q2 koss Cooperative Advertising And Promotion Allowances
CooperativeAdvertisingAndPromotionAllowances
158770
CY2021Q2 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1008
CY2021Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
150000
CY2020Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
150000
CY2021Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
83463
CY2020Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
80399
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
73200
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
68200
CY2021Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
38199
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8098
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
70175
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
53647
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48516
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44622
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
665567
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
580099
CY2021 us-gaap Net Income Loss
NetIncomeLoss
493594
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-465597
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7864688
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7404831
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1774585
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9639273
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7404831
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2786225
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1223200
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M19D
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
619137
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
549594
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.12
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.74
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0034
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2592875
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.77
CY2019Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6.28
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M23D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
48280
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
555000
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceLowerLimit
1.97
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceUpperLimit
2.17
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.08
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
362000
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceLowerLimit
2.20
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceUpperLimit
6.28
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.53
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
64000
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Forfeitures In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsForfeituresInPeriodExercisePriceUpperLimit
2.65
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.15
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2721875
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6.00
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.73
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M25D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
615000
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceLowerLimit
1.73
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodExercisePriceUpperLimit
2.11
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.84
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1203875
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceLowerLimit
1.77
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercises In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisesInPeriodExercisePriceUpperLimit
6.00
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
385000
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceLowerLimit
1.77
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Expirations In Period Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationsInPeriodExercisePriceUpperLimit
5.24
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.24
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1748000
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceLowerLimit
1.73
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Outstanding Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsOutstandingExercisePriceUpperLimit
6.00
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.29
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M9D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
36594280
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1408709
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceLowerLimit
1.77
CY2020Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceUpperLimit
6.00
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.12
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y7M9D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
288000
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Lower Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceLowerLimit
1.73
CY2021Q2 koss Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercise Price Upper Limit
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisePriceUpperLimit
6.00
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.19
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y9M21D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
5767425
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
31877285
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3306272
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
550093
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
483461
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
6545430
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1272584
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.19
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
555000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
450418
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.07
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
64000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
1.39
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1313166
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.26
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
615000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.12
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
468166
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.17
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1460000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.23
CY2021Q2 koss Treasury Stock Repurchase Price Percentage Of Fair Value Of Common Stock
TreasuryStockRepurchasePricePercentageOfFairValueOfCommonStock
0.95
CY2021Q2 koss Stock Repurchase Program Amount To Provide Proceeds Limitation
StockRepurchaseProgramAmountToProvideProceedsLimitation
2500000
CY2021Q2 koss Percentage Of Promissory Note Due
PercentageOfPromissoryNoteDue
0.25
CY2021 koss Contingent Promissory Note Term
ContingentPromissoryNoteTerm
P4Y
CY2021Q2 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
2000000
CY2021 koss Lease Extension Per Year
LeaseExtensionPerYear
380000
CY2021Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
380000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
380000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
380000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
380000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0425
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0425
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
380000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
380000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
380000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
380000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
380000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
760000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2660000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
354545
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2305455
CY2020 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0
CY2021 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
0
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.75
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
79481
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
252293
CY2021 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
385000
CY2020Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
41000
CY2021Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
41000

Files In Submission

Name View Source Status
0000056701-21-000024-index-headers.html Edgar Link pending
0000056701-21-000024-index.html Edgar Link pending
0000056701-21-000024.txt Edgar Link pending
0000056701-21-000024-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
koss-20210630.xsd Edgar Link pending
koss-20210630x10k.htm Edgar Link pending
koss-20210630x10k_htm.xml Edgar Link completed
koss-20210630xex23_1.htm Edgar Link pending
koss-20210630xex31_1.htm Edgar Link pending
koss-20210630xex31_2.htm Edgar Link pending
koss-20210630xex32_1.htm Edgar Link pending
koss-20210630xex32_2.htm Edgar Link pending
koss-20210630_cal.xml Edgar Link unprocessable
koss-20210630_def.xml Edgar Link unprocessable
koss-20210630_lab.xml Edgar Link unprocessable
koss-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending